Tocainide is effective in the symptomatic treatment of myotonic syndromes f
or its ability to reduce the high Frequency discharges of action potentials
typical of the disease, by blocking voltage-gated sodium channels. However
, its use is restricted by serious side effects. In spite of its chiral str
ucture, tocainide is clinically used as a racemic mixture. Since the optica
l isomers may differ in their efficacy and toxicity, the present study was
aimed at evaluating the antimyotonic activity of the pure R(-) and S(+) ena
ntiomers of tocainide, on the abnormal membrane hyperexcitability of extern
al intercostal muscle fibers of congenitally myotonic goats. The excitabili
ty parameters were recorded in vitro by means of the standard two-microelec
trode current-clamp technique before and after the addition of the compound
s. The R(-) enantiomer of tocainide at concentrations as low as 10 mu M pot
ently counteracted the abnormal excitability of myotonic fibers, by increas
ing the threshold current, and decreasing the latency of the action potenti
al and firing capability. Also, this concentration of R-(-) tocainide almos
t completely abolished the abnormal spontaneous electrical activity occurri
ng in about 70-80% of the myotonic fiber. The S(+) enantiomer was remarkabl
y Less potent since up to 100 mu M did not restore the normal excitability
pattern. The results show that most of the antimyotonic activity of tocaini
de resides in the R(-) enantiomer suggesting that its clinical use may allo
w a significant reduction of the doses and possibly of the side effects. (C
) 2000 Elsevier Science B.V. All rights reserved.